Addressing the spectrum of hypercholesterolemia.
作者信息
Grundy S M, Mazzaferri E L
机构信息
University of Texas Southwestern Medical Center at Dallas, USA.
出版信息
Hosp Pract (1995). 1996 Jun 15;31(6):43-8, 53-5, 59; discussion 60.
PMID:8675545
Abstract
The past decade has seen a major shift in management: Trials of HMG-CoA reductase inhibitors have suggested that cholesterol reduction offers greater protection against coronary artery disease than does antihypertensive therapy. Five patient vignettes provide guidelines for initiating therapy. The agents should be prescribed with restraint, often not until other measures have been exhausted.
摘要
相似文献
1
Addressing the spectrum of hypercholesterolemia.
Hosp Pract (1995). 1996 Jun 15;31(6):43-8, 53-5, 59; discussion 60.
2
3
The statin trials: closing arguments in the case against cholesterol?他汀类药物试验：反对胆固醇的结案陈词？
Scott Med J. 1996 Aug;41(4):99-100. doi: 10.1177/003693309604100401.
4
[Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].[辛伐他汀治疗中重度高胆固醇血症患者的有效性和耐受性。一项为期12个月的研究结果]
Minerva Cardioangiol. 1993 Mar;41(3):105-9.
5
[The 4-S study--a turning point in the cholesterol debate. Work Group Lipids and Atherosclerosis of the Swiss Society for Cardiology].[4S研究——胆固醇争论的转折点。瑞士心脏病学会脂质与动脉粥样硬化工作组]
Praxis (Bern 1994). 1995 Dec 19;84(51-52):1514-6.
6
[The problem of hypercholesterolemia in the aged].[老年人高胆固醇血症问题]
Minerva Cardioangiol. 1990 Oct;38(10):415-21.
7
[Maximal therapy of hypercholesterolemia in coronary heart disease].
Ther Umsch. 1990 Jun;47(6):520-9.
8
Treating hypercholesterolemia aggressively.积极治疗高胆固醇血症。
Nebr Med J. 1996 Jan;81(1):3-4.
9
Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
N Z Med J. 1990 Feb 14;103(883):41-3.
10
[Current developments in prevention of coronary heart disease].[冠心病预防的当前进展]
Z Arztl Fortbild (Jena). 1996 Feb;90(1):7-10.
Zotero 插件